169321 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
METHODS TO DIAGNOSE A REQUIRED REGULATION OF TROPHOBLAST INVASION
#902Method of using CCR3 binding agents to detect choroidal neovascularization
#903Methods of utilizing the arrestin-2/STAM-1 complex as a therapeutic target
#904Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#905HUMAN TUMOR NECROSIS FACTOR TR21 AND METHODS BASED THEREON
#906Human monoclonal antibodies to CTLA-4
#907IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES
#908MIF antagonists
#909Methods of treatment using antibodies to Neutrokine-alpha
#910Dual variable domain immunoglobulins and uses thereof
#911Cell-mediated immunoassays
#912Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#913Interleukin-1 Alpha Antibodies and Methods of Use
#914Method for diagnosing allergic reactions
#915Interleukin-1 alpha antibodies and methods of use
#916IP-10 BASED IMMUNOLOGICAL MONITORING
#917Interleukin-1α antibodies and methods of use
#918Method of determining the nucleotide sequence of Oligonucleotides and DNA molecules
#919Interleukin-1 alpha antibodies and methods of use
#920DIAGNOSTIC MARKERS OF WOUND INFECTION
#921BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#922Therapeutic Agents
#923Methods and kits for predicting a response to an erythropoietic agent
#924SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSE
#925Cells screening method
#926Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#927Immunoassay method for human CXCL1 protein
#928METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#929Methods of diagnosing and predicting renal disease
#930BIOMARKERS FOR PREDICTING RAPID RESPONSE TO HCV TREATMENT
#931Methods for prevention and treatment of inflammation using anti-chemokine antibodies
#932METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#933Method for Evaluating The Immunogenicity of Proteins
#934CCR3 inhibition for ocular angiogenesis and macular degeneration
#935Cytokines and Cytokine Receptors with Reduced Immunogenicity
#936DIFFERENTIATING BETWEEN FIBROSIS AND CIRRHOSIS
#937METHOD FOR ASSESSMENT OF SEVERITY OF LIVER CIRRHOSIS
#938Methods and reagents for diagnosing rheumatoid arthrtis
#939MARKERS FOR DETERMINATION OF PATIENT RESPONSIVENESS
#940TNF-α binding proteins
#941TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS
#942EGFR DEPENDENT MODULATION OF CHEMOKINE EXPRESSION AND INFLUENCE ON THERAPY AND DIAGNOSIS OF TUMORS AND SIDE EFFECTS THEREOF
#943Markers for determination of patient responsiveness
#944Methods for assessing drug efficacy and response of patient to therapy
#945Assay for analysis of free drug in samples
#946PREPARATION METHOD
#947ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR
#948THERAPEUTIC USE OF FARNESYLTRANSFERASE INHIBITORS AND METHODS OF MONITORING THE EFFICACY THEREOF
#949DIAGNOSIS AND TREATMENT OF BACK PAIN
#950Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#951Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#952Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#953METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#954LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE
#955TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
#956Response Element Regions
#957COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
#958IL-17 RECEPTOR LIKE MOLECULES AND USES THEREOF
#959Methods of determining efficacy of treatments of diseases of the bowel
#960EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA
#961CYTOKINE RECEPTOR MODULATORS AND USES THEREOF
#962METHOD FOR DIAGNOSING AND TREATING EMPHYSEMA
#963NEURTURIN RECEPTOR
#964Multiplexed Analyses of Test Samples
#965Compositions and methods for diagnosis, prognosis and management of malaria
#966MULTIMARKER PANEL FOR MONITORING PATIENTS WITH AND WITHOUT OVERT HEART FAILURE
#967USE OF CELL LINES TO DETERMINE LEVELS OF EFFICACY OF PHARMACEUTICAL FORMULATIONS
#968ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
#969Diagnosis and/or prognosis of renal dysfunction
#970Human CDR-grafted antibody and antibody fragment thereof
#971Future cardiac event biomarkers CCL3, CCL5 and CCL18
#972NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#973COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
#974Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#975METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION
#976DOMAIN ANTIBODY CONSTRUCT
#977Diagnostic and therapeutic epitope, and transgenic plant
#978Diagnosis and treatment of wound infection with procalcitonin as diagnostic marker
#979METHODS OF PROGNOSIS
#980Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1
#981GDF-15 AS BIOMARKER IN TYPE 1 DIABETES
#982PD-1, A Receptor for B7-4, and Uses Therefor
#983Endothelial monocyte activation polypeptide II, a biomarker for use in diagnosis and treatment of brain injury
#984ANTI-BRAK (CXCL14) HUMAN MONOCLONAL ANTIBODY AND USE THEREOF
#985Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#986CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME
#987Systems and methods for collecting tear film and measuring tear film osmolarity
#988TNFalpha GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS
#989Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#990ZAP-70 as predictor and modulator of effector function of T cells
#991METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA
#992Cytokine production-inducing antibody
#993Heteroduplex tracking assay
#994Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
#995CHEMOKINE-BINDING PROTEIN AND METHODS OF USE
#996DIAGNOSTIC TEST
#997Methods of delivery of exogenous proteins to the cytosol and uses thereof
#998ASSAY
#999Ninjurin-1 modulation and uses thereof
#1000METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
#1001DETERMINING DISEASE OR IMMUNE SYSTEM FEATURES BASED ON ANALYSIS OF IMMUNE SYSTEM CHARACTERISTICS
#1002Methods of treatment using a vector encoding p21/
#1003CCL18 and CCL3 methods and compositions for detecting and treating cancer
#1004Diagnostic Methods and Arrays for Use in the Same
#1005Anti-CD40 targeted fusion proteins
#1006Method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-α
#1007Fusion protein with HIV antigen
#1008Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system
#1009Method of identifying transmembrane protein-interacting compounds
#1010AGENTS AND METHODS FOR MODULATING MACROPHAGE INHIBITORY CYTOKINE (MIC-1) ACTIVITY
#1011REAGENTS THAT BIND CCX-CKR2
#1012Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents
#1013Compositions and methods for diagnosing and treating prostate cancer
#1014Method for efficient production of monocyte-derived multipotent cell (MOMC)
#1015NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#1016TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
#1017Salivary bioassay for early detection of bone loss
#1018SEROLOGICAL MARKERS OF INFLAMMATORY BOWEL DISEASE PHENOTYPE AND DISEASE PROGRESSION
#1019ASSAYS FOR DETERMINING EXPOSURE TO MULTIWALLED CARBON NANOTUBES
#1020PHARMACEUTICALS COMPOSITIONS COMPRISING ACTINOMYCETE GLYCEROL ACYL DERIVATIVES ANTIGENS, THEIR PROCESS OF EXTRACTION, AND THEIR USE AGAINST TUBERCULOSIS
#1021NATRIURETIC PEPTIDE/GDF-15 RATIO FOR DIAGNOSIS OF CARDIAC DISORDERS
#1022ASSESSMENT AND REDUCTION OF RISK OF GRAFT-VERSUS-HOST DISEASE
#1023Use of the Serological Assay of the Cytokine B-Lymphocyte Stimulator (Blys) as a Prognostic and Monitoring Test for Immune-Related Transfusion Reactions
#1024Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
#1025Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms
#1026Minimally-invasive measurement of esophageal inflammation
#1027Pharmaceutical peptides for the treatment of inflammatory diseases
#1028Use of lymphocytes to measure anthrax lethal toxin activity
#1029Cell-mediated immune response assay and kits therefor
#1030Assay method for peptide specific T-cells
#1031Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#1032Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#1033Method of screening baff suppressor or inhibitor
#1034Methods of use of the TACI/TACI-L interaction
#1035Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
#1036Method for Analyzing Clinical Trial Results for Efficacy of a Therapy
#1037Nanoelectronic-enzyme linked immunosorbent assay system and method
#1038INTERLEUKIN 6 AND TUMOR NECROSIS FACTOR ALPHA AS BIOMARKERS OF JNK INHIBITION
#1039METHOD FOR DETECTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE
#1040COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#1041Composition and Method for Analysis of Target Analytes
#1042Anti-CD27 antibody
#1043METHODS FOR IDENTIFICATION AND PREDICTION OF MULTIPLE SCLEROSIS DISEASE AND THERAPY RESPONSE
#1044Diagnose of mycobacterial infections by determination of IFN-gamma
#1045Diagnostic markers of wound infection
#1046Assessing heart failure in patients with atrial fibrillation using GDF-15 and natriuretic peptides
#1047Assays and methods using biomarkers
#1048OSTEOPONTIN FUNCTIONAL EPITOPES, MONOCLONAL ANTIBODIES AGAINST THE EPITOPES AND USES THEREOF
#1049Thiophene derivatives for up-regulating HLA-DM activity
#1050MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF
#1051Cytokines and Genes Differentially Affected by TNF Blockers
#1052THERAPEUTIC AGENTS
#1053Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#1054Artery- and vein-specific proteins and uses therefor
#1055DISEASE MARKERS
#1056Stabilized bacterial formulation
#1057Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes
#1058Methods and compositions for diagnosing and monitoring transplant rejection
#10594-1 bb ligand in inflammatory diseases
#1060Injection moulding method
#1061IP-10 based immunological monitoring
#1062Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#1063CYTOKINE RECEPTOR CHAIN
#1064Agent detection and/or quantitation in a biological fluid
#1065IL-1 ZETA, IL-1 ZETA SPLICE VARIANTS AND XREC2 DNAS AND POLYPEPTIDES
#1066Method for determining human immunodeficiency virus (HIV) coreceptor utilization by examining gp41 molecular determinants
#1067METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1068Human Tumor Necrosis Factor TR21 and Methods Based Thereon
#1069Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
#1070Preparation Method
#1071Modulation of T helper cell-mediated immune responses
#1072Antibodies that bind human OX2 receptors
#1073Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
#1074Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels
#1075METHOD OF USING CYTOKINE ASSAY TO DIAGNOSE, TREAT, AND EVALUATE INFLAMMATORY AND AUTOIMMUNE DISEASES
#1076DIFFERENTIAL CYTOKINE EXPRESSION IN HUMAN CANCER
#1077METHODS FOR DIAGNOSING AND PREDICTING NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#1078Dual variable domain immunoglobulins and uses thereof
#1079Interleukin-1α antibodies
#1080Cynomolgus gp80 receptor and uses thereof
#1081IL-17 receptor like molecules and uses thereof
#1082Method of controlling hair shape
#1083Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
#1084Method of treatment using an anti-IL-B50 antibody
#1085LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS
#1086Purified TNFR preparations
#1087Diagnostic And Therapeutic Epitope, And Transgenic Plant
#1088Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
#1089Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
#1090Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#1091Cytokines and Cytokine Receptors With Reduced Immunocencity
#1092Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins
#1093METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE DETECTION OF MOLECULES
#1094MOLECULES AND CHIMERIC MOLECULES THEREOF
#1095Human CDR-grafted antibody and antibody fragment thereof
#1096Platelet aggregation assays using a CD40L-binding agent
#1097Acute renal injury
#1098LITAF binding site peptides and methods of using the same
#1099EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS
#1100AGENT FOR CONTROL OF DEGRANULATION REACTION AND CYTOKINE PRODUCTION
#1101Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues
#1102Methods of Diagnosing and Treating an Inflammatory Response
#1103SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#1104Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions
#1105Inflammation-inhibitory serum factors and uses thereof
#1106Neutrokine-alpha antibodies and methods of use thereof
#1107Biomarkers for the diagnosis of autoimmune disease
#1108Tissue Protective Cytokine Receptor Complex, Assays for Identifying Tissue Protective Compounds and Uses Thereof
#1109Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
#1110Treatment of inflammation using α7 receptor-binding cholinergic agonists
#1111CCR3 inhibition for ocular angiogenesis and macular degeneration
#1112Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
#1113CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME
#1114INHIBITION OF TRISTETRAPROLINE FOR PROTECTION OF THE HEART FROM CARDIAC INJURIES
#1115Methods for early diagnosing of an increased risk of preeclampsia
#1116Anti-p55 TNF receptor antibody
#1117Methods of use of the TACI/TACI-L interaction
#1118Method of identifying transmembrane protein-interacting compounds
#1119Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6
#1120Method to Identify CD40-Sensitive Cells Using Gene Expression
#1121Endothelial-monocyte activating polypeptide II, a biomarker for use in diagnosis of brain injury
#1122Molecular phenotyping of severe asthma
#1123Methods of treatment using antibodies to neutrokine-alpha
#1124Compositions for detecting and treating diseases and conditions related to chemokine receptors
#1125Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
#1126BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#1127Cytokine receptor modulators and uses thereof
#1128Heteroduplex tracking assay
#1129Chemokine receptor antagonists as therapeutic agents
#1130Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer
#1131ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1 INFECTED PATIENTS
#1132Attractin/mahogany-like polypeptides
#1133MARKERS FOR ATHEROSCLEROSIS
#1134Methods for monitoring patients with severe sepsis and septic shock and for selecting treatments for these patients
#1135Method of screening Baff suppressor or inhibitor
#1136Chemokine Ccl18 as a Biomarker
#1137Method for diagnosing and treating acute joint injury
#1138Chemokine panec-1 antibodies
#1139COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#1140Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
#1141Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
#1142Methods for screening for compounds that modulate PD-1 signaling
#1143Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
#1144Methods and Compositions for Diagnosis and Treatment of Disorders Involving Macrophages
#1145Methods of evaluating BAFF
#1146Treatment of trauma-hemorrhage with short oligopeptides
#1147Methods and kits for the diagnosis of galactosemia
#1148Methods and kits for the diagnosis of sickle cell
#1149Composition and method for modulating an inflammatory response
#1150Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
#1151Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
#1152ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1-INFECTED PATIENTS
#1153Methods of treatment involving p21/CIP1
#1154CD25+ DIFFERENTIAL MARKERS AND USES THEREOF
#1155Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
#1156Systems And Methods For Characterizing Contrast Induced-Nephropathy
#1157Egfr Dependent Modulation of Chemokine Expression and Influence on Therapy and Diagnosis of Tumors and Side Effects Thereof
#1158Anti-human VEGF receptor Flt-1 monoclonal antibody
#1159Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
#1160Methods for identifying modulators of tumor necrosis factor receptors
#1161Diagnostic and therapeutic epitope, and transgenic plant
#1162Human OX2 receptors
#1163Pharmaceutical compositions for treating arthritis and inflammatory disease
#1164Drug Identification and Treatment Method
#1165Method for the diagnosis of chronic stress and related disorders
#1166Systems and methods for collecting tear film and measuring tear film osmolarity
#1167Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#1168Non-elispot assay
#1169Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases
#1170Methods of treating with anti-C5/C5a specific antibodies
#1171Uses and compositions for treatment of juvenile rheumatoid arthritis
#1172Early Detection of Sepsis
#1173Oral killed vaccines and method for providing same
#1174PHARMACEUTICAL COMPOSITIONS FOR TREATING ARTHRITIS AND INFLAMMATORY DISEASE
#1175Simultaneous assay of target and target-drug binding
#1176Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
#1177Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods
#1178FUNCTION HOMOLOGY SCREENING
#1179FUNCTION HOMOLOGY SCREENING
#1180BIOMAP ANALYSIS
#1181Methods of regulating cytokine signalling
#1182Method for determining antigen-specific T cell response in high throughput format
#1183WSX-1/P28 as a target for anti-inflammatory responses
#1184Antibody profiling for determination of patient responsiveness
#1185Diagnostic and prognostic methods and compositions of matter for cell proliferative diseases
#1186Hematopoietin receptors HPR1 and HPR2
#1187Heteroduplex tracking assay
#1188Modulation of Programmed Necrosis
#1189METHODS FOR DIAGNOSING AND TREATING PAIN IN THE SPINAL CORD
#1190Use of Il-17 in the Treatment of Fertility-Related Disorders
#1191Diagnostic Method For The Forecasting Of Transplanted Organ Loosing
#1192Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#1193Relevance of achieved levels of markers of systemic inflammation following treatment
#1194Ligand for herpes simplex virus entry mediator and methods of use
#1195Systems and methods for identifying organ transplant risk
#1196CMKLR regulation of adipogenesis and adipocyte metabolic function
#1197Recombinant polypeptides of the members of the TNF ligand family and use thereof
#1198COMPOSITIONS AND METHODS FOR ANALYSIS OF TARGET ANALYTES
#1199Therapeutic uses of chemokine variants
#1200Inflammatory Cytokine Inhibitors